| 000 -LEADER |
|---|
| fixed length control field |
01758cam a22003014a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
vtls003228090 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MY-SjTCS |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200226115119.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
111213s2010 nyua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781607415657 (hbk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1607415658 (hbk.) |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
|---|
| Level of rules in bibliographic description |
201203141159 |
| Level of effort used to assign nonsubject heading access points |
shuhada |
| Level of effort used to assign subject headings |
201203141152 |
| Level of effort used to assign classification |
shuhada |
| Level of effort used to assign subject headings |
201202211614 |
| Level of effort used to assign classification |
izani |
| -- |
201112131628 |
| -- |
malathy |
| 043 ## - GEOGRAPHIC AREA CODE |
|---|
| Geographic area code |
n-us--- |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.190083 |
| Item number |
SAF 2010 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Safety efforts in pediatric drug development / |
| Statement of responsibility, etc. |
Conor D. Byrne, editor. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
New York : |
| Name of publisher, distributor, etc. |
Nova Science Publishers, |
| Date of publication, distribution, etc. |
c2010. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 133 p. : |
| Other physical details |
ill. ; |
| Dimensions |
23 cm. |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Pharmacology--research, safety testing and regulation series |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO. |
| 610 10 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
United States. |
| Title of a work |
Best Pharmaceuticals for Children Act. |
| 9 (RLIN) |
58536 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pediatric pharmacology |
| Geographic subdivision |
United States. |
| 9 (RLIN) |
58537 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pediatrics |
| Geographic subdivision |
United States |
| General subdivision |
Formulae, receipts, prescriptions |
| -- |
Safety measures. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug development |
| Geographic subdivision |
United States |
| General subdivision |
Safety measures. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Byrne, Conor D. |
| 9 (RLIN) |
58538 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Pharmacology--research, safety testing and regulation series. |
| 9 (RLIN) |
59642 |
| 920 ## - Programme |
|---|
| Programme |
PHA : 177941 |
| 999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
|---|
| Koha biblionumber |
143434 |
| Koha biblioitemnumber |
143434 |
